Andrew Weng

Researcher
  • BC Cancer Research Institute
  • University of British Columbia
Home > About Us > Our People > Researcher Bio
  • Bio

Related Research

  • Blood Cancers

    Strategies to divert malignant potentials in acute leukemia

    Understanding acute leukemia is like trying to solve a complex puzzle. The DNA sequence of our cells forms the puzzle pieces, but these pieces can change their appearance – and alter the overall...

    Read More
  • Blood Cancers

    Modeling lymphoma evolution and clinical trajectory using multiomics

    It’s their fifth cycle of funding for researchers at the BC Cancer Centre for Lymphoid Cancer who are part of the renewal of a coveted Terry Fox New Frontiers Program Projects Grant, following t...

    Read More
  • Completed
    Blood Cancers

    Exploiting pathogenic mechanisms in acute leukemia for clinical translation

    A longstanding Terry Fox-funded project on hard-to-treat leukemias has been renewed, and the new injection of funds – $6.3 million over five years – will help to furthe...

    Read More
  • Completed
    Blood Cancers

    Overcoming treatment failure in lymphoid cancers

    TFRI’s prolific lymphoid cancer team began their research with a simple question: “Why do two-thirds of lymphoma patients recover, while the remainder does not?” A decade later their...

    Read More
  • Completed
    Blood Cancers

    Core pathogenic pathways in human leukemia

    Treatment for acute myeloid leukemia (AML), one of the most aggressive forms of leukemia, involves chemotherapy drugs that many patients find difficult to tolerate and long-term survival is low. New t...

    Read More

Related News & Events

  • Research Highlight|January 09, 2020

    Newly created synthetic cancer cells help advance understanding of leukemias

    For the first time ever, a team of TFRI-funded researchers has created synthetic cancer cells that are indistinguishable from T-cell acute lymphoblast...

  • Research Highlight|January 15, 2019

    Restoring stem cells to a fetal-like state could provide a therapeutic alternative for acute leukemias

    A team of TFRI-funded scientists in Vancouver has discovered that restoring a signaling pathway that is prevalent in fetal stem cells but dormant in a...

  • All News & Events